Mark Lowery

NASAR A CHAUDHRY, PHYSICIAN, PLLC

327 SENECA RD

Articles

Sales of leukemia chemotherapy drug suspended

November 05, 2013

Citing the risk of life-threatening blood clots and severe narrowing of blood vessels, FDA has asked Ariad Pharmaceuticals to suspend marketing and sales of ponatinib (Iclusig).